Abstracts by key term: Type 2 diabetes
Health preference research plays a crucial role in supporting patients and physicians in shared decision-making. Such studies reveal what is important to patients in their treatment, thereby enabling recommendations that better meet their needs – improving individualized care, promoting treatment adherence, and potentially reducing complications (Cramer 2004). The presented study investigated the value of treatments by assessing patient preferences. The aim was to gain scientifically sound insights into the preferences of people with type 2 diabetes. In particular, the study examined which aspects are important to patients when choosing medications for combination therapy.
05.10.2025
This study examined the costs of a combination therapy of exenatide (EXE) and an oral antidiabetic drug (OAD) versus basal-supported oral therapy (BOT) with insulin glargine (GLA) in antihyperglycemic treatment in type 2 diabetics in Germany based on healthcare data . A historical cohort study was conducted using the representative IMS® Disease Analyzer database. Type 2 diabetics who started BOT with GLA or combination therapy with EXE and OAD between 1/2007 and 12/2008 were included.
23.09.2012
The patient empowerment approach to training chronically ill people aims to help patients gain more autonomy in the care of their illness and improve their self-management skills. Based on this philosophy, the European Health Care Foundation has developed a training and care concept for healthcare professionals and chronically ill people. The core is a training portal for standardized coach training and care for patients with type 2 diabetes. The training concept was tested in a multicenter prospective study in German pharmacies. The Caoches and the patients rated the training material as good or very good, patients were able to manage their illness better through the training and 70% of the diabetes patients improved their HbA1c value by a mean of 0.7%